Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q1 2026 Earnings Call Transcript May 6, 2026
Sarepta Therapeutics, Inc. beats earnings expectations. Reported EPS is $2.88, expectations were $0.976.
Operator: Good afternoon, and welcome to Sarepta Therapeutics, Inc.’s First Quarter 2026 Earnings Results Call. As a reminder, today’s program is being recorded. I would now like to turn the call over to Tamara Thornton, Sarepta Therapeutics, Inc.’s Director of Investor Relations. Please go ahead.
Tamara...
